Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Hiroyuki Ikuta, Hiroaki Shimada, Kenjiro Sakamoto, Rena Nakamura, Atsushi Kawase & Masahiro Iwaki. (2022) Species differences in liver microsomal hydrolysis of acyl glucuronide in humans and rats. Xenobiotica 52:7, pages 653-660.
Read now
Read now
Takashi Koyanagi, Koji Yano, Soonih Kim, Norie Murayama, Hiroshi Yamazaki & Ikumi Tamai. (2019) In vivo hepatic clearance of lipophilic drugs predicted by in vitro uptake data into cryopreserved hepatocytes suspended in sera of rats, guinea pigs, monkeys and humans. Xenobiotica 49:8, pages 887-894.
Read now
Read now
Kathleen M. Knights & John O. Miners. (2010) Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators. Drug Metabolism Reviews 42:1, pages 63-73.
Read now
Read now
Shufeng Zhou, Philip Kestell & James W. Paxton. (2002) PREDICTING PHARMACOKINETICS AND DRUG INTERACTIONS IN PATIENTS FROM IN VITRO AND IN VIVO MODELS: THE EXPERIENCE WITH 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (DMXAA), AN ANTI-CANCER DRUG ELIMINATED MAINLY BY CONJUGATION. Drug Metabolism Reviews 34:4, pages 751-790.
Read now
Read now
S. F. Zhou, M. D. Tingle, P. Kestell & J. W. Paxton. (2002) Species differences in the metabolism of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid in vitro : implications for prediction of metabolic interactions in vivo. Xenobiotica 32:2, pages 87-107.
Read now
Read now
Michael B. Fisher, Mary F. Paine, Timothy J. Strelevitz & Steven A. Wrighton. (2001) The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*†. Drug Metabolism Reviews 33:3-4, pages 273-297.
Read now
Read now
Articles from other publishers (14)
John O. Miners, Thomas M. Polasek, Julie-Ann Hulin, Andrew Rowland & Robyn Meech. (2023) Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance. Pharmacology & Therapeutics 248, pages 108459.
Crossref
Crossref
Hiroaki Shimada, Hiroyuki Ikuta, Keisuke Kumazawa, Manato Nomi, Mayumi Shiojiri, Atsushi Kawase & Masahiro Iwaki. (2022) Relationship between the risk of idiosyncratic drug toxicity and formation and degradation profiles of acyl-glucuronide metabolites of nonsteroidal anti-inflammatory drugs in rat liver microsomes. European Journal of Pharmaceutical Sciences 174, pages 106193.
Crossref
Crossref
Jin Zhou & John O. Miners. 2014. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
203
228
.
Alexander V. LyubimovShalu Jhajra, Ninad Ramesh Varkhede, Deepak Suresh Ahire, Bukke Vidyasagar Naik, Bhagwat Prasad, Jyoti Paliwal & Saranjit Singh. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
99
.
Alexander V. LyubimovRobert S. Foti, Dan A. Rock, Larry C. Wienkers & Jan L. Wahlstrom. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
68
.
Alexander V. LyubimovRobert S. Foti & Michael B. Fisher. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
71
.
Lauren Oleson & Michael H Court. (2008) Effect of the β-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases. Journal of Pharmacy and Pharmacology 60:9, pages 1175-1182.
Crossref
Crossref
Kathleen M. Knights, Leanne K. Winner, David J. Elliot, Kushari Bowalgaha & John O. Miners. (2009) Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP‐glucuronosyltransferases: Inhibition by NSAIDs. British Journal of Clinical Pharmacology 68:3, pages 402-412.
Crossref
Crossref
Chuanhui Yu, Joseph K. Ritter, Richard J. Krieg, Bhaskar Rege, Thomas H. Karnes & Mohamadi A. Sarkar. (2006) EFFECT OF CHRONIC RENAL INSUFFICIENCY ON HEPATIC AND RENAL UDP-GLUCURONYLTRANSFERASES IN RATS. Drug Metabolism and Disposition 34:4, pages 621-627.
Crossref
Crossref
Maria Shipkova, Victor William Armstrong, Michael Oellerich & Eberhard Wieland. (2003) Acyl Glucuronide Drug Metabolites: Toxicological and Analytical Implications. Therapeutic Drug Monitoring 25:1, pages 1-16.
Crossref
Crossref
Sam Boase & John O. Miners. (2002)
In vitro–in vivo
correlations for drugs eliminated by glucuronidation: Investigations with the model substrate zidovudine
. British Journal of Clinical Pharmacology 54:5, pages 493-503.
Crossref
Crossref
Khalid M. Alkharfy & Reginald F. Frye. (2001) High-performance liquid chromatographic assay for acetaminophen glucuronide in human liver microsomes. Journal of Chromatography B: Biomedical Sciences and Applications 753:2, pages 303-308.
Crossref
Crossref
Brian Burchell. 1999. Handbook of Drug Metabolism. Handbook of Drug Metabolism
153
173
.
Frank Bohnenstengel, Heyo K. Kroemer & Bernhard Sperker. (1999) In vitro cleavage of paracetamol glucuronide by human liver and kidney β-glucuronidase: determination of paracetamol by capillary electrophoresis. Journal of Chromatography B: Biomedical Sciences and Applications 721:2, pages 295-299.
Crossref
Crossref